[Radionuclide therapy for painful bone metastases].
The paper presents the possibilities of therapy of painful bone metastases, which result from nuclear medicine development. Authors discuss fundamental problems connected with radionuclide therapy. The emphasis is put on the efficiency and safety of this treatment for patients and their environment.
Szefer
Jarosław
J
Zakładu Medycyny Nuklearnej Regionalnego Centrum Onkologii w Bydgoszczy.
Zuchora
Zdzisław
Z
D001859:Bone Neoplasms / Q000532:radiotherapy* / Q000556:secondary*; D006801:Humans; D009942:Organometallic Compounds / Q000627:therapeutic use; D009943:Organophosphorus Compounds / Q000627:therapeutic use; D010146:Pain / Q000209:etiology* / Q000532:radiotherapy*; D010166:Palliative Care / Q000379:methods; D011868:Radioisotopes / Q000627:therapeutic use*; D019275:Radiopharmaceuticals / Q000627:therapeutic use*; D012493:Samarium / Q000627:therapeutic use; D013324:Strontium / Q000627:therapeutic use; D013326:Strontium Radioisotopes / Q000627:therapeutic use
D009942:Organometallic Compounds; D009943:Organophosphorus Compounds; D011868:Radioisotopes; D019275:Radiopharmaceuticals; D013326:Strontium Radioisotopes; D012493:Samarium; C061972:samarium Sm-153 lexidronam; D013324:Strontium